| 靶点: |
Androgen receptor |
| 体内研究: |
LY2452473 is a selective androgen receptor modulator being developed for the treatment of disorders related to hypogonadism. LY2452473 is absorbed rapidly (time to reach maximum plasma concentration for both LY2452473 and total radioactivity is 2-3 h) and cleared slowly (plasma terminal t1/2 of 27 h for LY2452473 and 51 h for the total radioactivity). |
| 参考文献: |
1. Yi P, et al. Disposition and metabolism of LY2452473, a selective androgen receptor modulator, in humans. Drug Metab Dispos. 2012 Dec;40(12):2354-64. |
| 保存条件: |
RT |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.671 ml |
13.353 ml |
26.707 ml |
| 5 mM |
0.534 ml |
2.671 ml |
5.341 ml |
| 10 mM |
0.267 ml |
1.335 ml |
2.671 ml |
| 50 mM |
0.053 ml |
0.267 ml |
0.534 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |